Collaborative Community Against Coronavirus (3C) CIC was formed in March 2020. Frustrated at the inability of the available treatments to control an emerging virus pandemic, the 3C team, formed of a group of leading industrial scientists, virologists, and medicinal chemists with a track record of designing inhibitors of diverse virus groups as antiviral medicines, immediately initiated research to prepare the world for future epidemics. Initial funding enabled the rapid use of this expertise against the Coronaviruses and initially SARS-CoV-2 (the virus responsible for COVID-19). The team have discovered exciting and widely varied lead molecules against this virus and work is now focussed on refining these leads as excellent starting points for control of any future coronavirus epidemic.
Copyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.